AU Stock MarketDetailed Quotes
ATX Amplia Therapeutics Ltd
- 0.102
- -0.003-2.86%
20min DelayTrading Nov 5 13:30 AET
28.60MMarket Cap-4636P/E (Static)
0.110High0.102Low317.00KVolume0.110Open0.105Pre Close33.26KTurnover0.18052wk High0.19%Turnover Ratio280.37MShares0.05552wk Low-0.022EPS TTM17.34MFloat Cap167.493Historical HighLossP/E (Static)169.95MShs Float0.041Historical Low-0.022EPS LYR7.62%Amplitude--Dividend TTM2.49P/B1Lot Size--Div YieldTTM
About Amplia Therapeutics Ltd Company
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure-play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Company Profile
SymbolATX
Company NameAmplia Therapeutics Ltd
Founded2013
MarketASX
Fiscal Year Ends03-31
Address350 Queen Street Level 17
CityMelbourne
CountryAustralia
Zip Code3000
Phone+61 280033650
Websitehttps://www.ampliatx.com
Share RegistryCOMPUTERSHARE INVESTOR SERVICES PTY LIMITED
Yarra Falls, 452 Johnston Street, ABBOTSFORD, VIC, AUSTRALIA, 3067
03 9415 4000
Company Executives
- Name
- Position
- Salary
- Christopher John Burns
- Non Executive Director,Chief Executive Officer,Managing Director
- --
- Warwick Bonner Tong
- Non-Executive Director,Non-Executive Chairman
- --
- Robert Peach
- Non-Executive Director
- --
- Jane Catherine Bell
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data